EXOZ
eXoZymes, Inc.
6.30$
-0.7%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3.9% | +12.6% | +1.2% | -12.2% | +266.1% | -11.6% | -16.0% | -20.2% | -22.6% | -32.7% | +98.6% | |
| – | -7.4% | +34.9% | +8.8% | -20.2% | +660.6% | -13.0% | -20.0% | -25.6% | -29.7% | -46.9% | +195.2% | |
| – | -86.0% | +71.0% | +39.1% | +47.8% | +4,054.7% | -12.4% | -17.9% | -27.0% | -40.4% | -52.5% | +291.3% | |
| – | -86.0% | +71.0% | +39.1% | +47.8% | +4,054.7% | -12.4% | -17.9% | -27.0% | -40.4% | -52.5% | +291.3% | |
| – | +30.0% | +26.0% | +3.2% | -51.7% | +33.1% | -19.3% | -56.7% | +17.4% | +70.9% | -41.5% | -27.4% | |
| – | +39.9% | +33.3% | +20.2% | +13.4% | -63.5% | +1.2% | -7.7% | -4.0% | +9.8% | -3.2% | +73.8% | |
| – | +58.8% | +57.5% | +29.7% | +17.6% | -77.0% | +8.3% | -15.7% | +1.8% | +26.5% | +1.0% | +2.2% | |
| – | -6.5% | +7.2% | +1,190.4% | +16.9% | -93.7% | +2.9% | +20.9% | +10.7% | +2.9% | +2.7% | +2.6% | |
| – | +107.4% | +7.6% | -33.5% | +80.7% | +1.7% | +16.0% | -13.2% | -2.8% | +36.6% | -0.1% | +3.3% | |
| – | -163.3% | – | – | – | – | -14.8% | -18.5% | -25.7% | -36.8% | -55.0% | +139.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +3.0% | +0.1% | +0.1% | -0.1% | +0.9% | +2.4% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.